https://novapharmanews.com/ 2026-06-01T21:30:29.807Z weekly 1.0 https://novapharmanews.com/about 2026-06-01T21:30:29.807Z weekly 0.7 https://novapharmanews.com/about/data-sources 2026-06-01T21:30:29.807Z weekly 0.7 https://novapharmanews.com/team 2026-06-01T21:30:29.807Z weekly 0.7 https://novapharmanews.com/editorial-policy 2026-06-01T21:30:29.807Z weekly 0.7 https://novapharmanews.com/terms 2026-06-01T21:30:29.807Z weekly 0.7 https://novapharmanews.com/cookie-policy 2026-06-01T21:30:29.807Z weekly 0.7 https://novapharmanews.com/press 2026-06-01T21:30:29.807Z weekly 0.7 https://novapharmanews.com/services 2026-06-01T21:30:29.807Z weekly 0.7 https://novapharmanews.com/drugs 2026-06-01T21:30:29.807Z weekly 0.7 https://novapharmanews.com/companies 2026-06-01T21:30:29.807Z weekly 0.7 https://novapharmanews.com/patents 2026-06-01T21:30:29.807Z weekly 0.7 https://novapharmanews.com/projects 2026-06-01T21:30:29.807Z weekly 0.7 https://novapharmanews.com/whitepapers 2026-06-01T21:30:29.807Z weekly 0.7 https://novapharmanews.com/events 2026-06-01T21:30:29.807Z weekly 0.7 https://novapharmanews.com/us 2026-06-01T21:30:29.807Z daily 0.9 https://novapharmanews.com/us/news 2026-06-01T21:30:29.807Z hourly 0.85 https://novapharmanews.com/us/articles 2026-06-01T21:30:29.807Z daily 0.8 https://novapharmanews.com/us/about 2026-06-01T21:30:29.807Z monthly 0.5 https://novapharmanews.com/us/contact 2026-06-01T21:30:29.807Z monthly 0.5 https://novapharmanews.com/us/privacy-policy 2026-06-01T21:30:29.807Z yearly 0.3 https://novapharmanews.com/eu 2026-06-01T21:30:29.807Z daily 0.9 https://novapharmanews.com/eu/news 2026-06-01T21:30:29.807Z hourly 0.85 https://novapharmanews.com/eu/articles 2026-06-01T21:30:29.807Z daily 0.8 https://novapharmanews.com/eu/about 2026-06-01T21:30:29.807Z monthly 0.5 https://novapharmanews.com/eu/contact 2026-06-01T21:30:29.807Z monthly 0.5 https://novapharmanews.com/eu/privacy-policy 2026-06-01T21:30:29.807Z yearly 0.3 https://novapharmanews.com/apac 2026-06-01T21:30:29.807Z daily 0.9 https://novapharmanews.com/apac/news 2026-06-01T21:30:29.807Z hourly 0.85 https://novapharmanews.com/apac/articles 2026-06-01T21:30:29.807Z daily 0.8 https://novapharmanews.com/apac/about 2026-06-01T21:30:29.807Z monthly 0.5 https://novapharmanews.com/apac/contact 2026-06-01T21:30:29.807Z monthly 0.5 https://novapharmanews.com/apac/privacy-policy 2026-06-01T21:30:29.807Z yearly 0.3 https://novapharmanews.com/us/news/plozasiran-tga-approval-australia-redemplo-fcs 2026-06-01 daily 0.8 https://novapharmanews.com/eu/news/purdue-pharma-shutdown-oxycontin-settlement 2026-06-01 daily 0.8 https://novapharmanews.com/apac/news/fda-approves-auvelity-mdd-new-antidepressant 2026-06-01 daily 0.8 https://novapharmanews.com/apac/news/plozasiran-tga-approval-australia-redemplo-fcs 2026-06-01 daily 0.8 https://novapharmanews.com/us/articles/plozasiran-tga-approval-australia-redemplo- FCS 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/dia-2024-regulatory-preview 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/bio-it-world-conference-oncology-day-1 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/fierce-biotech-week-highlights-trends 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/us-japan-healthcare-conf-2026-highlights 2026-06-01 daily 0.8 https://novapharmanews.com/apac/news/pda-manufacturing-apac-highlights 2026-06-01 daily 0.8 https://novapharmanews.com/apac/news/pda-apac-pharma-manufacturing-day-1-roundup 2026-06-01 daily 0.8 https://novapharmanews.com/apac/news/pda-apac-manufacturing-innovations-day1 2026-06-01 daily 0.8 https://novapharmanews.com/apac/news/pda-apac-manufacturing-day-1-roundup 2026-06-01 daily 0.8 https://novapharmanews.com/apac/news/apac-clinical-event-preview 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/asgct-manufacturing-innovations 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/fdli-2026-annual-highlights 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/aphl-2026-highlights-innovations 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/APHL-2026-annual-day-1-roundup 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/fdli-annual-2026-regulatory-insights-policy-updates 2026-06-01 daily 0.8 https://novapharmanews.com/eu/news/swiss-biotech-day-key-innovations-partnerships 2026-06-01 daily 0.8 https://novapharmanews.com/eu/news/raps-euro-convergence-regulatory-updates-day-1 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/cellenkos-fda-clearance-ck0802-phase-2a-trial-steroid-refractory-gvhd 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/fda-approves-guardant360-cdx-veppanu-breast-cancer-diagnostic 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/clene-cnm-au8-fda-accelerated-approval-als-treatment-2024 2026-06-01 daily 0.8 https://novapharmanews.com/apac/news/arrowhead-pharmaceuticals-tga-approval-redemplo-plozasiran-australia-fcs 2026-06-01 daily 0.8 https://novapharmanews.com/eu/news/vanda-pharmaceuticals-nereus-tradipitant-motion-sickness-drug-launch 2026-06-01 daily 0.8 https://novapharmanews.com/eu/news/pulse-biosciences-atrial-fibrillation-treatment-100-percent-success-rate-2026 2026-06-01 daily 0.8 https://novapharmanews.com/eu/news/biocryst-navenibart-european-licensing-deal-neopharmed-gentili 2026-06-01 daily 0.8 https://novapharmanews.com/eu/news/fda-approves-langlara-biosimilar-lantus-insulin-lannett-company 2026-06-01 daily 0.8 https://novapharmanews.com/eu/news/vertex-casgevy-gene-therapy-global-expansion-q1-2026-results 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/crispr-therapeutics-casgevy-global-approvals-60000-patients 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/clene-cnm-au8-fda-accelerated-approval-pathway-als-treatment 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/novartis-fabhalta-health-canada-approval-c3g-treatment 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/alpha-tau-alpha-dart-pancreatic-cancer-trials-ddw-2026 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/celcuity-gedatolisib-phase-3-viktoria-1-trial-pik3ca-mutant-cancer 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/fda-approves-langlara-interchangeable-biosimilar-lantus-insulin-lannett 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/fda-approves-guardant360-cdx-companion-diagnostic-pfizer-veppanu-breast-cancer 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/fda-approves-incyte-jakafi-xr-extended-release-myelofibrosis 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/arvinas-veppanu-vepdegestrant-fda-approval-first-protac-drug-esr1-breast-cancer 2026-06-01 daily 0.8 https://novapharmanews.com/eu/news/eular-2026-immutep-imp761-phase-1-preview 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/excipient-world-conference-day-1-highlights 2026-06-01 daily 0.8 https://novapharmanews.com/apac/news/ucb-acquires-candid-therapeutics-2-2-billion-t-cell-engager-autoimmune 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/niktimvo-axatilimab-approved-australia-chronic-gvhd-treatment 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/biomarin-voxzogo-achondroplasia-long-term-data-pes-2026 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/fda-approves-incyte-jakafi-xr-extended-release-myelofibrosis-polycythemia-vera 2026-06-01 daily 0.8 https://novapharmanews.com/apac/news/apotex-generic-ozempic-semaglutide-health-canada-approval-2026 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/neurocrine-crenessity-two-year-pediatric-cah-study-results 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/novo-nordisk-oral-ozempic-fda-approved-pill-glp1-type-2-diabetes-cardiovascular 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/axsome-auvelity-fda-approval-alzheimers-agitation-treatment 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/arvinas-fda-approval-veppanu-vepdegestrant-protac-esr1-breast-cancer 2026-06-01 daily 0.8 https://novapharmanews.com/apac/news/prolacta-human-milk-fortifiers-prescription-drug-status-japan-jasmine-trial 2026-06-01 daily 0.8 https://novapharmanews.com/eu/news/uniqure-amt-130-gene-therapy-uk-approval-huntingtons-disease 2026-06-01 daily 0.8 https://novapharmanews.com/eu/news/fda-advisory-committee-recommends-astrazeneca-truqap-pten-deficient-prostate-cancer 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/mrm-health-mh002-fda-fast-track-ulcerative-colitis 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/summit-therapeutics-ivonescimab-overall-survival-lung-cancer-asco-2026 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/ac-immune-final-cohort-abate-trial-anti-abeta-alzheimer-treatment 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/fda-advisory-committee-recommends-astrazeneca-truqap-pten-deficient-prostate-cancer 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/eli-lilly-foundayo-orforglipron-fda-approval-obesity-q1-2026-results 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/theradaptive-fda-approval-osteoadapt-sp-phase-3-spinal-fusion-trial 2026-06-01 daily 0.8 https://novapharmanews.com/apac/news/immunitybio-securities-fraud-lawsuit-anktiva-fda-warning-letter 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/viking-therapeutics-vk2735-phase-3-obesity-trials-enrolled-q1-2026 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/perimeter-medical-claire-oct-ai-fda-approval-breast-cancer-surgery 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/regeneron-q1-2026-earnings-dupixent-eylea-hd-sales-growth 2026-06-01 daily 0.8 https://novapharmanews.com/eu/news/biopharma-clinical-trials-eu-daily-insights 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/clinical-outsourcing-2026-key-takeaways 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/clinical-outsourcing-trends-2026-key-takeaways 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/ieee-cog-2026-industry-day-game-dev-tutorials 2026-06-01 daily 0.8 https://novapharmanews.com/apac/news/insilico-rentosertib-inhalation-ind-clearance-ai-drug-clinical-trial 2026-06-01 daily 0.8 https://novapharmanews.com/eu/news/european-commission-approves-poherdy-pertuzumab-biosimilar-henlius-organon 2026-06-01 daily 0.8 https://novapharmanews.com/eu/news/x4-pharmaceuticals-xolremdi-mavorixafor-european-approval-whim-syndrome 2026-06-01 daily 0.8 https://novapharmanews.com/eu/news/norgine-xolremdi-mavorixafor-whim-syndrome-european-approval 2026-06-01 daily 0.8 https://novapharmanews.com/eu/news/norgine-xolremdi-mavorixafor-european-approval-whim-syndrome-treatment 2026-06-01 daily 0.8 https://novapharmanews.com/eu/news/henlius-organon-poherdy-first-pertuzumab-biosimilar-approved-europe 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/teva-acquires-emalex-ecopipam-tourette-syndrome-drug 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/pfizer-elrexfio-progression-free-survival-multiple-myeloma-phase-3-trial 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/fda-priority-review-gilead-bictegravir-lenacapavir-hiv-treatment 2026-06-01 daily 0.8 https://novapharmanews.com/eu/news/eu-biopharma-clinical-trials-daily-roundup 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/pharma-partnering-us-biotech-deals 2026-06-01 daily 0.8 https://novapharmanews.com/apac/news/chinabio-partnering-forum-biotech-deals-investment 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/pharma-partnering-us-biotech-deals-day-1 2026-06-01 daily 0.8 https://novapharmanews.com/apac/news/claruvis-retoxin-first-recombinant-botulinum-toxin-approval-china 2026-06-01 daily 0.8 https://novapharmanews.com/eu/news/silexion-therapeutics-sil204-phase-2-3-trial-kras-pancreatic-cancer 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/aclaris-ati-052-phase-1a-trial-results-45-day-half-life 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/astrazeneca-breztri-aerosphere-approved-first-triple-therapy-asthma-patients-12-older 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/vensica-medical-fda-ind-approval-vixe-xeomin-needle-free-delivery-overactive-bladder 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/abbvie-upadacitinib-rinvoq-fda-application-alopecia-areata 2026-06-01 daily 0.8 https://novapharmanews.com/apac/news/chinabio-partnering-forum-biotech-investment-trends 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/ascrs-2026-opus-genetics-phentolamine-preview 2026-06-01 daily 0.8 https://novapharmanews.com/apac/news/wuxi-apptec-q1-2026-revenue-growth-backlog-results 2026-06-01 daily 0.8 https://novapharmanews.com/apac/news/biomarin-completes-amicus-therapeutics-acquisition-galafold-pompe-therapies 2026-06-01 daily 0.8 https://novapharmanews.com/eu/news/opella-essentiale-excel-trial-fatty-liver-disease-masld-results 2026-06-01 daily 0.8 https://novapharmanews.com/eu/news/mundipharma-rezzayo-rezafungin-phase-iii-respect-trial-results-fungal-disease-prevention 2026-06-01 daily 0.8 https://novapharmanews.com/eu/news/crinetics-palsonify-paltusotine-eu-approval-acromegaly-treatment 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/cellenkos-fda-clearance-ck0801-phase-2-aplastic-anemia-trial 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/intellia-lonvo-z-fda-submission-crispr-hereditary-angioedema 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/intellia-lonvoguran-ziclumeran-phase-3-hereditary-angioedema-gene-editing 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/fda-priority-review-imaavy-nipocalimab-warm-autoimmune-hemolytic-anemia 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/fda-approves-caplyta-lumateperone-snda-schizophrenia-relapse-prevention 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/acrp-2026-patient-centric-trials-workforce 2026-06-01 daily 0.8 https://novapharmanews.com/eu/news/reuters-pharma-ai-patient-centricity 2026-06-01 daily 0.8 https://novapharmanews.com/eu/news/reuters-pharma-eu-funding-dealmaking-highlights 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/adagio-medical-vclas-ventricular-ablation-system-pivotal-trial-results 2026-06-01 daily 0.8 https://novapharmanews.com/eu/news/ema-positive-opinion-redemplo-plozasiran-european-approval 2026-06-01 daily 0.8 https://novapharmanews.com/eu/news/ema-approves-first-rna-veterinary-vaccine-nobivac-nxt-cats 2026-06-01 daily 0.8 https://novapharmanews.com/eu/news/ema-approves-plozasiran-redemplo-familial-chylomicronaemia-syndrome-fcs 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/fda-approves-otarmeni-first-gene-therapy-genetic-hearing-loss 2026-06-01 daily 0.8 https://novapharmanews.com/eu/news/clinuvel-scenesse-phase-iii-vitiligo-trial-ema-approval-2026 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/novartis-coartem-baby-who-prequalification-malaria-treatment-newborns 2026-06-01 daily 0.8 https://novapharmanews.com/apac/news/catalym-visugromab-phase-2-3-trial-cancer-cachexia-first-patient-dosed 2026-06-01 daily 0.8 https://novapharmanews.com/apac/news/spinogenix-spg601-clarity-trial-fragile-x-syndrome-phase-2b-3 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/cortec-brain-interchange-bci-fda-tap-program-stroke-rehabilitation 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/fda-approves-regeneron-otarmeni-gene-therapy-genetic-hearing-loss 2026-06-01 daily 0.8 https://novapharmanews.com/apac/news/minjuvi-tafasitamab-approved-australia-follicular-lymphoma 2026-06-01 daily 0.8 https://novapharmanews.com/eu/news/healthcare-third-party-logistics-market-growth-502-billion-2034 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/mabwell-9mw2821-nectin-4-adc-phase-iii-triple-negative-breast-cancer 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/cipla-fda-approval-first-generic-ventolin-hfa-albuterol-sulfate 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/dupixent-approved-chronic-spontaneous-urticaria-children-sanofi 2026-06-01 daily 0.8 https://novapharmanews.com/us/news/oncology-data-trends-2026-preview 2026-06-01 daily 0.8 https://novapharmanews.com/eu/news/reuters-pharma-day-1-eu-takeaways 2026-06-01 daily 0.8 https://novapharmanews.com/eu/news/belite-bio-tinlarebant-nda-submission-stargardt-disease-phase-3-dragon-trial 2026-06-01 daily 0.8 https://novapharmanews.com/drugs/abacavir-sulfate 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/abiraterone-acetate 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/acamprosate-calcium 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/acebutolol-hydrochloride 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/aceclidine-hydrochloride 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/acetaminophen 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/acetazolamide 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/acetazolamide-sodium 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/acetohexamide 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/acetylcysteine 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/acitretin 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/acoramidis-hydrochloride 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/acyclovir 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/acyclovir-sodium 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/adalimumab-aqvh 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/adenosine 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/adenovirus-mediated-herpes-simplex-virus-thymidine-kinase-gene 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/aflibercept 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/agalsidase-alfa 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/albuterol 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/albuterol-sulfate 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/alendronate-sodium 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/alirocumab 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/aliskiren 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/allopurinol 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/almotriptan-malate 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/alogliptin 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/alogliptin-benzoate 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/alosetron-hydrochloride 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/alprazolam 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/alvimopan 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/amantadine-hydrochloride 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/amifampridine-phosphate 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/amiloride-hydrochloride 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/aminocaproic-acid 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/aminophylline 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/aminosalicylate-sodium 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/amiodarone-hydrochloride 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/amitriptyline-hydrochloride 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/amlodipine-benzoate 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/amlodipine-besylate 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/ammonia-n-13 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/amoxapine 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/amoxicillin 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/amphetamine-adipate 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/amphetamine-aspartate 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/amphetamine-sulfate 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/amphotericin-b 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/ampicillin-sodium 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/ampicillin-ampicillin-trihydrate 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/anagrelide 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/anagrelide-hydrochloride 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/anastrozole 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/apixaban 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/apomorphine 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/apremilast 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/aprepitant 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/arformoterol-tartrate 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/argatroban 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/arimoclomol-citrate 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/aripiprazole 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/armodafinil 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/arsenic-trioxide 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/asparaginase-erwinia-chrysanthemi-recombinant-rywn 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/aspirin 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/atazanavir-sulfate 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/atenolol 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/atoltivimab 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/atomoxetine-hydrochloride 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/atorvastatin-calcium 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/atovaquone 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/atracurium-besylate 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/atropine-sulfate 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/avutometinib-potassium 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/axitinib 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/azacitidine 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/azathioprine 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/azelaic-acid 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/azelastine-hydrochloride 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/azilsartan-medoxomil 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/azithromycin 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/baclofen 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/beclomethasone-dipropionate 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/bempedoic-acid 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/benazepril-hydrochloride 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/benzgalantamine-gluconate 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/benztropine-mesylate 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/beremagene-geperpavec 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/berotralstat 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/berotralstat-dihydrochloride 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/besilesomab 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/betaine 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/betamethasone-acetate 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/betamethasone-dipropionate 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/betamethasone-valerate 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/bethanechol-chloride 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/bevacizumab 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/bevacizumab-maly 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/bexarotene 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/bicalutamide 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/bimatoprost 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/binimetinib 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/bisoprolol-fumarate 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/bivalirudin 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/bleomycin-sulfate 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/bortezomib 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/bosentan 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/brentuximab-vedotin 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/brexpiprazole 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/brigatinib 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/brimonidine-tartrate 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/brivaracetam 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/bromfenac-sodium 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/brompheniramine-maleate 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/budesonide 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/bumetanide 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/bupivacaine 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/bupivacaine-hydrochloride 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/buprenorphine 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/buprenorphine-hydrochloride 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/bupropion-hydrochloride 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/buspirone-hydrochloride 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/busulfan 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/butabarbital-sodium 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/c1-inhibitor-human 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/cabazitaxel 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/cabergoline 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/cabozantinib 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/caffeine-citrate 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/calcitonin-salmon 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/calcitriol 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/calcium-acetate 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/calcium-chloride 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/calcium-gluconate 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/calcium-oxybate 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/calfactant 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/canagliflozin 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/candesartan-cilexetil 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/cannabidiol 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/cantharidin 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/capecitabine 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/captopril 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/carbamazepine 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/carbinoxamine-maleate 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/carboplatin 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/carboprost-tromethamine 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/carfilzomib 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/carisoprodol 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/carmustine 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/carvedilol 2026-05-26 monthly 0.75 https://novapharmanews.com/companies/4d-molecular-therapeutics 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/60-degrees-pharmaceuticals-inc 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/abeona-therapeutics-inc 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/abvc-biopharma-inc 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/actuate-therapeutics-inc 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/adc-therapeutics-sa 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/adial-pharmaceuticals-inc 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/aeon-biopharma 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/alterity-therapeutics-ltd 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/alx-oncology-holdings-inc 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/an2-therapeutics 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/ani-pharmaceuticals-inc 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/artelo-biosciences-inc 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/assembly-biosciences-inc 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/atossa-therapeutics-inc 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/avenue-therapeutics-inc 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/axim-biotechnologies-inc 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/aytu-biopharma-inc 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/acadia-pharmaceuticals-inc 2026-05-26 monthly 0.75 https://novapharmanews.com/companies/aclaris-therapeutics 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/acrivon-therapeutics 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/actinium-pharmaceuticals 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/acumen-pharmaceuticals 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/acurx-pharmaceuticals 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/adaptive-biotechnologies-corp 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/addex-therapeutics 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/agios-pharmaceuticals-inc 2026-05-26 monthly 0.75 https://novapharmanews.com/companies/agomab-therapeutics-nv 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/akari-therapeutics-plc 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/akebia-therapeutics 2026-05-26 monthly 0.75 https://novapharmanews.com/companies/aktis-oncology 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/alaunos-therapeutics 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/aldeyra-therapeutics 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/aligos-therapeutics 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/allarity-therapeutics 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/allogene-therapeutics 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/mira-pharmaceuticals-inc 2026-05-26 monthly 0.75 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc 2026-05-26 monthly 0.75 https://novapharmanews.com/companies/altamira-therapeutics 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/amneal-pharmaceuticals 2026-05-26 monthly 0.75 https://novapharmanews.com/companies/amphastar-pharmaceuticals 2026-05-26 monthly 0.75 https://novapharmanews.com/companies/amylyx-pharmaceuticals 2026-05-26 monthly 0.75 https://novapharmanews.com/companies/anebulo-pharmaceuticals 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/nika-pharmaceuticals-inc 2026-05-26 monthly 0.75 https://novapharmanews.com/companies/anixa-biosciences-inc 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/apellis-pharmaceuticals 2026-05-26 monthly 0.75 https://novapharmanews.com/companies/apimeds-pharmaceuticals-us 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/apogee-therapeutics 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/aprea-therapeutics 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/aptevo-therapeutics 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/aptose-biosciences 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/aquestive-therapeutics 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/arbutus-biopharma-corp 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/arcturus-therapeutics-holdings 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/arcus-biosciences 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/arcutis-biotherapeutics 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/aardvark-therapeutics 2026-05-26 monthly 0.75 https://novapharmanews.com/companies/armata-pharmaceuticals 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/arrivent-biopharma 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/arrowhead-pharmaceuticals-inc 2026-05-26 monthly 0.75 https://novapharmanews.com/companies/ars-pharmaceuticals 2026-05-26 monthly 0.75 https://novapharmanews.com/companies/artiva-biotherapeutics 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/aspire-biopharma-holdings 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/atea-pharmaceuticals 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/atrium-therapeutics 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/aura-biosciences 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/aurinia-pharmaceuticals 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/autolus-therapeutics-plc 2026-05-26 monthly 0.75 https://novapharmanews.com/companies/avalo-therapeutics 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/axsome-therapeutics 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/beone-medicines 2026-05-26 monthly 0.75 https://novapharmanews.com/companies/bicycle-therapeutics 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/brainstorm-cell-therapeutics-inc 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/bright-minds-biosciences-inc 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/barinthus-biotherapeutics-plc 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/beam-therapeutics 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/benitec-biopharma 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/bicara-therapeutics 2026-05-23 monthly 0.75 https://novapharmanews.com/companies/biomarin-pharmaceutical-inc 2026-05-26 monthly 0.75 https://novapharmanews.com/companies/bioxcel-therapeutics 2026-05-23 monthly 0.75 https://novapharmanews.com/apac/category/medical-imaging?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/apac/category/corporate-reporting?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/apac/category/healthcare-economics?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/apac/category/cns-disorders?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/eu/category/autoimmune-diseases?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/eu/category/generic-drugs?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/us/category/immunology?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/apac/category/vaccines?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/eu/category/rare-diseases 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/us/category/hiv-treatment?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/eu/category/immunology 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/apac/category/lung-cancer 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/us/category/spine-treatment?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/us/category/sexual-health?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/apac/category/drug-distribution?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/eu/category/pediatric-diseases?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/eu/category/insurance-regulation?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/apac/category/consumer-health?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/us/category/pain-management?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/eu/category/medical-technology?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/apac/category/licensing 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/eu/category/biologics?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/apac/category/biopharma?type=analysis 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/apac/category/cell-therapy?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/apac/category/manufacturing?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/eu/category/motion-sickness?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/eu/category/cancer-detection?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/us/category/colorectal-cancer?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/apac/category/regulatory-strategy?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/apac/category/neurovascular?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/eu/category/healthcare-infrastructure?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/apac/category/wound-management?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/us/category/fda-oversight?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/us/category/women-s-health?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/us/category/pharmaceutical-services?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/apac/category/medical-technology?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/apac/category/nutrition?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/eu/category/regulatory-affairs?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/us/category/cancer-treatment?type=news 2026-06-01T21:30:29.807Z weekly 0.65 https://novapharmanews.com/eu/category/fertility?type=news 2026-06-01T21:30:29.807Z weekly 0.65